Evidence map›Paper›PMID 38494078›Full record

ArticleThe Journal of molecular diagnostics : JMD2024

Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal Swabs.

Michelle Qi, Anissa R Naranjo, Abigail J Duque, Thomas S Lorey, Jeffrey M Schapiro, Betty J Suh-Burgmann, Michael Rummel, Stephen J Salipante, Nicolas Wentzensen, Dina N Greene

Open access · hybridAbstract readEvaluation Study
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Michelle QiLetsGetChecked Laboratories, Monrovia, California.
Anissa R NaranjoLetsGetChecked Laboratories, Monrovia, California.
Abigail J DuqueThe Permanente Medical Group, Northern California Kaiser Permanente Regional Reference Laboratory, Oakland, California.
Thomas S LoreyThe Permanente Medical Group, Northern California Kaiser Permanente Regional Reference Laboratory, Oakland, California.
Jeffrey M SchapiroThe Permanente Medical Group, Northern California Kaiser Permanente Regional Reference Laboratory, Oakland, California.
Betty J Suh-BurgmannDepartment of Research, The Permanente Medical Group, Oakland, California.
Michael RummelLetsGetChecked Laboratories, Monrovia, California.
Stephen J SalipanteDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
Nicolas WentzensenDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Dina N GreeneLetsGetChecked Laboratories, Monrovia, California; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington. Electronic address: dngreene@uw.edu.
Instituto Piaget · PTKaiser Permanente · USUniversity of Washington · USColorado Permanente Medical Group · USNational Cancer Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus (HPV) primary screening is an effective approach to assessing cervical cancer risk. Self-collected vaginal swabs can expand testing access, but the data defining analytical performance criteria necessary for adoption of self-collected specimens are limited, especially for those occurring outside the clinic, where the swab remains dry during transport. Here, we evaluated the performance of self-collected vaginal swabs for HPV detection using the Cobas 6800. There was insignificant variability between swabs self-collected by the same individual (n = 15 participants collecting 5 swabs per participant), measured by amplification of HPV and human β-globin control DNA. Comparison of self-collected vaginal swab and provider-collected cervical samples (n = 144 pairs) proved highly concordant for HPV detection (total agreement = 90.3%; positive percentage agreement = 84.2%). There was no relationship between the number of dry storage days and amplification of HPV (n = 68; range, 4 to 41 days). Exposure of self-collected dry swabs to extreme summer and winter temperatures did not affect testing outcomes. A second internal control (RNase P) demonstrated that lack of amplification for β-globin from self-collected specimens was consistent with poor, but not absent, cellularity. These data suggest that self-collected vaginal samples enable accurate clinical HPV testing, and that extended ambient dry storage or exposure to extreme temperatures does not influence HPV detection. Furthermore, lack of β-globin amplification in HPV-negative samples accurately identified participants who required recollection.

Indexed as

Human Papillomavirus VirusesPapillomavirus InfectionsSpecimen HandlingAdultDNA, ViralEarly Detection of CancerFemaleHumansMass ScreeningMiddle AgedUterine Cervical NeoplasmsVaginaVaginal SmearsDNA, Viral

Identifiers

PMID38494078
PMCPMC11238274
OpenAlexW4392868018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.